Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m. ET. A live webcast will be available on the company investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
News Market Reaction – IART
In the Dec 2 session, IART gained 0.77%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | Investor conference | Neutral | +0.8% | Management scheduled to present at Citi 2025 Global Healthcare Conference. |
| Nov 25 | Reimbursement update | Positive | +6.2% | Medicare rules expanded uniform reimbursement for multiple Integra skin substitutes. |
| Nov 11 | Regulatory clearance | Positive | +1.2% | FDA 510(k) clearance extended CUSA Clarity use to cardiac surgeries. |
| Oct 30 | Quarterly earnings | Positive | -23.5% | Q3 2025 showed revenue and EPS growth but stock fell sharply. |
| Oct 15 | Earnings call notice | Neutral | -1.2% | Announcement of Q3 2025 results release and conference call timing. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive regulatory and reimbursement updates often saw gains, but the latest earnings release coincided with a sharp decline.
This announcement follows several material developments for Integra LifeSciences in late 2025. On Nov 25, the company highlighted Medicare policy changes that improved reimbursement for its wound products, and on Nov 11 it received FDA 510(k) clearance expanding CUSA Clarity’s use to cardiac surgery. However, Q3 2025 results on Oct 30 triggered a -23.46% move despite revenue and EPS growth. Against this backdrop, the Citi conference appearance on Dec 3, 2025 is a routine investor-relations event rather than a new fundamental catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
